OnKure Therapeutics (OKUR) EBITDA (2020 - 2026)
OnKure Therapeutics' EBITDA was -$16.81 million in Q2 2026, compared with -$16.21 million a year earlier.
Powered by 
Analysis
OnKure Therapeutics (OKUR) EBITDA (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, OnKure Therapeutics' EBITDA was -$61.74 million through Jun 30, 2026; for FY2025, it came in at -$62.5 million.
- In earlier years, EBITDA was -$53.93 million in FY2024, -$36.52 million in FY2023, -$53.76 million in FY2022 and -$39.77 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2025.
- Per Business Quant data, OKUR's EBITDA in the three quarters before Q2 2026 was -$15.51 million (Q1 2026), -$14.02 million (Q4 2025) and -$15.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | 5.89 Bn |
| 10 | OnKure Therapeutics | 116.79 Mn | -381.13 Mn | - | -16.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.81 Mn |
| Mar 31, 2026 | -15.51 Mn |
| Dec 31, 2025 | -14.02 Mn |
| Sep 30, 2025 | -15.39 Mn |
| Jun 30, 2025 | -16.21 Mn |
| Mar 31, 2025 | -16.88 Mn |
| Dec 31, 2024 | -18.57 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -14.23 Mn |
| Mar 31, 2024 | -9.72 Mn |
| Dec 31, 2023 | 21.40 Mn |
| Sep 30, 2023 | -20.85 Mn |
| Jun 30, 2023 | -21.00 Mn |
| Mar 31, 2023 | -16.08 Mn |
| Dec 31, 2022 | -14.54 Mn |
| Sep 30, 2022 | -13.82 Mn |
| Jun 30, 2022 | -12.41 Mn |
| Mar 31, 2022 | -13.00 Mn |
| Dec 31, 2021 | -10.61 Mn |
| Sep 30, 2021 | -12.74 Mn |
API Access
OnKure Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();